SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000737207-20-000030
Filing Date
2020-08-19
Accepted
2020-08-19 12:29:37
Documents
47
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atrx-20200630.htm   iXBRL 10-Q 1141747
2 EX-31.1 atrx-20200630xex311.htm EX-31.1 12828
3 EX-32.1 atrx-20200630xex321.htm EX-32.1 6594
  Complete submission text file 0000737207-20-000030.txt   4433103

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atrx-20200630.xsd EX-101.SCH 30999
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atrx-20200630_cal.xml EX-101.CAL 43083
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atrx-20200630_def.xml EX-101.DEF 158997
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atrx-20200630_lab.xml EX-101.LAB 403679
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atrx-20200630_pre.xml EX-101.PRE 252587
9 EXTRACTED XBRL INSTANCE DOCUMENT atrx-20200630_htm.xml XML 686321
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 201116159
SIC: 2834 Pharmaceutical Preparations